Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. https://doi.org/10.1136/archdischild-2015-310299

Sweet DG, Carnielli VP, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023;120:3. https://doi.org/10.1159/000528914.

Article  PubMed  Google Scholar 

Abdel-Latif ME, Davis PG, Wheeler KI, et al. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2021. https://doi.org/10.1002/14651858.CD011672.PUB2.

Article  PubMed  PubMed Central  Google Scholar 

Kumar P, Denson SE, Mancuso TJ, et al. Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics. 2010;125:608–15. https://doi.org/10.1542/PEDS.2009-2863.

Article  PubMed  Google Scholar 

Ancora G, Lago P, Garetti E, et al. Evidence-based clinical guidelines on analgesia and sedation in newborn infants undergoing assisted ventilation and endotracheal intubation. Acta Paediatr. 2019;108:208–17. https://doi.org/10.1111/APA.14606.

Article  PubMed  Google Scholar 

Ozawa Y, Ades A, Foglia EE, et al. Premedication with neuromuscular blockade and sedation during neonatal intubation is associated with fewer adverse events. J Perinatol. 2019;39:848–56. https://doi.org/10.1038/S41372-019-0367-0.

Article  PubMed  Google Scholar 

Balakrishnan A, Sanghera RS, Boyle EM. New techniques, new challenges—the dilemma of pain management for less invasive surfactant administration? Paediatr Neonatal Pain. 2021;3:2–8. https://doi.org/10.1002/PNE2.12033.

Article  PubMed  Google Scholar 

Peterson J, Den Boer MC, Roehr CC. To sedate or not to sedate for less invasive surfactant administration: an ethical approach. Neonatology. 2021;118:639–46. https://doi.org/10.1159/000519283.

Article  PubMed  Google Scholar 

Tribolet S, Hennuy N, Snyers D, et al. Analgosedation before less-invasive surfactant administration: a systematic review. Neonatology. 2022;119:137–50. https://doi.org/10.1159/000521553.

Article  PubMed  Google Scholar 

McDonald D, Palsgraf H, Shah P. Dexmedetomidine—an emerging option for sedation in neonatal patients. J Perinatol. 2022;42:845–55. https://doi.org/10.1038/S41372-022-01351-3.

Article  CAS  PubMed  Google Scholar 

Curtis S, Kilpatrick R, Billimoria ZC, et al. Use of dexmedetomidine and opioids in hospitalized preterm infants. JAMA Netw Open. 2023;6:e2341033–e2341033. https://doi.org/10.1001/JAMANETWORKOPEN.2023.41033.

Article  PubMed  PubMed Central  Google Scholar 

O’Mara K, Gal P, Wimmer J, et al. Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates. J Pediatr Pharmacol Ther. 2012;17:252–62. https://doi.org/10.5863/1551-6776-17.3.252.

Article  PubMed  PubMed Central  Google Scholar 

Leister N, Yücetepe S, Ulrichs C, et al. Dexmedetomidine as a sole sedative for procedural sedation in preterm and neonate infants: a retrospective analysis. Paediatr Anaesth. 2022;32:907–15. https://doi.org/10.1111/PAN.14461.

Article  PubMed  Google Scholar 

Guillen-Hernandez J, Kyllonen KC, Tumin D, Rodriguez RJ. The use of dexmedetomidine in preterm infants: a single academic center experience. J Pediatr Pharmacol Ther. 2023;28:628–34. https://doi.org/10.5863/1551-6776-28.7.628.

Article  PubMed  PubMed Central  Google Scholar 

Chandrasekharan P, Rawat M, Reynolds AM, et al. Apnea, bradycardia and desaturation spells in premature infants—impact of a protocol for duration of “Spell-Free” observation on inter-provider variability and readmission rates. J Perinatol. 2018;38:86. https://doi.org/10.1038/JP.2017.174.

Article  CAS  PubMed  Google Scholar 

Tin W. Systolic blood pressure in babies of less than 32 weeks gestation in the first year of life. Northern Neonatal Nursing Initiative. Arch Dis Child Fetal Neonatal Ed. 1999. https://doi.org/10.1136/FN.80.1.F38.

Article  Google Scholar 

Vittner D, Butler S, Lawhon G, Buehler D. The newborn individualised developmental care and assessment program: a model of care for infants and families in hospital settings. Acta Paediatr. 2024. https://doi.org/10.1111/APA.17300.

Article  PubMed  Google Scholar 

Hummel P, Puchalski M, Creech SD, Weiss MG. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain. J Perinatol. 2008;28:55–60. https://doi.org/10.1038/SJ.JP.7211861.

Article  CAS  PubMed  Google Scholar 

Dekker J, Lopriore E, Rijken M, et al. Sedation during minimal invasive surfactant therapy in preterm infants. Neonatology. 2016;109:308–13. https://doi.org/10.1159/000443823.

Article  CAS  PubMed  Google Scholar 

Krajewski P, Szpecht D, Hożejowski R. Premedication practices for less invasive surfactant administration—results from a nationwide cohort study. J Matern Fetal Neonatal Med. 2022;35:4750–4. https://doi.org/10.1080/14767058.2020.1863365.

Article  CAS  PubMed  Google Scholar 

Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration—a survey. Eur J Pediatr. 2017;176:147–54. https://doi.org/10.1007/S00431-016-2812-9/METRICS.

Article  PubMed  Google Scholar 

Pichler K, Kuehne B, Dekker J, et al. Assessment of comfort during less invasive surfactant administration in very preterm infants: a multicenter study. Neonatology. 2023;120:473. https://doi.org/10.1159/000530333.

Article  PubMed  Google Scholar 

Moschino L, Ramaswamy VV, Reiss IKM, et al. Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis. Pediatr Res. 2022;93(3):471–91. https://doi.org/10.1038/s41390-022-02121-9.

Article  CAS  PubMed  Google Scholar 

Cabrera OH, Useinovic N, Maksimovic S, et al. Neonatal ketamine exposure impairs infrapyramidal bundle pruning and causes lasting increase in excitatory synaptic transmission in hippocampal CA3 neurons. Neurobiol Dis. 2022;175: 105923. https://doi.org/10.1016/J.NBD.2022.105923.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalopita K, Armakolas A, Philippou A, et al. Ketamine-induced neurotoxicity in neurodevelopment: a synopsis of main pathways based on recent in vivo experimental findings. J Anaesthesiol Clin Pharmacol. 2021;37:37–42. https://doi.org/10.4103/JOACP.JOACP_415_19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhutta AT. Ketamine: a controversial drug for neonates. Semin Perinatol. 2007;31:303–8. https://doi.org/10.1053/J.SEMPERI.2007.07.005.

Article  PubMed  Google Scholar 

Barends CRM, Absalom A, van Minnen B, et al. Dexmedetomidine versus midazolam in procedural sedation. A systematic review of efficacy and safety. 2017. https://doi.org/10.1371/journal.pone.0169525.

Tervonen M, Pokka T, Kallio M, Peltoniemi O. Systematic review and meta-analysis found that intranasal dexmedetomidine was a safe and effective sedative drug during paediatric procedural sedation. Acta Paediatr. 2020;109:2008–16. https://doi.org/10.1111/APA.15348.

Article  CAS  PubMed  Google Scholar 

Chopra P, Dixit MB, Dang A, Gupta V. Dexmedetomidine provides optimum conditions during awake fiberoptic intubation in simulated cervical spine injury patients. 2016. https://doi.org/10.4103/0970-9185.175666.

He XY, Cao JP, He Q, Shi XY. Dexmedetomidine for the management of awake fibreoptic intubation. Cochrane Database Syst Rev. 2014. https://doi.org/10.1002/14651858.CD009798.PUB2.

Article  PubMed  PubMed Central  Google Scholar 

Mantecón-Fernández L, Lareu-Vidal S, González-López C, et al. Dexmedetomidine: an alternative to pain treatment in neonatology. Children. 2023. https://doi.org/10.3390/CHILDREN10030454.

Article  PubMed  PubMed Central  Google Scholar 

O’Mara K, Weiss MD. Dexmedetomidine for sedation of neonates with HIE undergoing therapeutic hypothermia: a single-center experience. AJP Rep. 2018;8: e168. https://doi.org/10.1055/S-0038-1669938.

Article  PubMed